Evidence map›Paper›PMID 42227713›Full record

ArticleThe Journal of physiology2026

FURIN induces vascular endothelial cell death and efferocytosis through enzymatic cleavage of thrombospondin-1.

Runji Chen, Daifei Shen, Amandine Mahieux, Dedrick Song, Shiwan Wu, Xiaoxin Huang, Xu Yang, Kunwei Chen, David G McVey, Elisa A Liehn and 2 more

Abstract read
In one paragraph

Article in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Runji ChenDepartment of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.ORCID https://orcid.org/0000-0002-3364-2507
Daifei ShenResearch Center of Translational Medicine, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Amandine MahieuxCardiovascular-Metabolic Disease Translational Research Programme, National University of Singapore, Singapore, Singapore.
Dedrick SongCardiovascular-Metabolic Disease Translational Research Programme, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0009-0001-2747-798X
Shiwan WuDepartment of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xiaoxin HuangDepartment of Basic Medicine, Shantou University Medical College, Shantou, China.
Xu YangResearch Center of Translational Medicine, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Kunwei ChenDepartment of Information, Tumor Hospital of Shantou University Medical College, Shantou, China.
David G McVeyDepartment of Cardiovascular Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-6402-2546
Elisa A LiehnCenter for Innovation and eHealth, University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania.
Roshni R SingarajaCardiovascular-Metabolic Disease Translational Research Programme, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0002-3418-3867
Shu YeDepartment of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.ORCID https://orcid.org/0000-0002-4126-4278

Funding

Medical Scientific Research Foundation of Guangdong Province of China A2023221National Medical Research Council of Singapore CIRG22jul-0002National Medical Research Council of Singapore CIRG23jul-0004National Natural Science Foundation of China 82070466National University of Singapore and National University Health System NUHSRO/2022/004/Startup/01
6 · The paper itself

Abstract

The vascular endothelium regulates molecular and cellular exchanges between the blood and tissues. Endothelial cell dysfunction and death, triggered by cardiovascular risk factors, can result in endothelial leakage, leading to atherosclerosis. Evidence indicates that the proprotein convertase FURIN can modulate endothelial cell behaviour and promote atherosclerosis. In this study, we investigated the underlying mechanisms: small interfering RNA (siRNA)-induced knockdown of FURIN reduced vascular endothelial cell (VEC) apoptosis and efferocytosis by monocyte-derived macrophages, whereas lentivirus-mediated overexpression of FURIN had the opposite effect. A co-immunoprecipitation assay and western blot analyses indicated that FURIN interacted with thrombospondin-1 (THBS1). Furthermore quantitative RT-PCR assays and western blot analyses showed that FURIN knockdown resulted in a decrease in THBS1 mRNA and protein levels, whereas THBS1 knockdown attenuated FURIN expression, and these reciprocal regulatory effects were augmented in the presence of LY2109761, an inhibitor of transforming growth factor-β receptors. THBS1 knockdown largely abolished the influence of FURIN on VEC apoptosis and efferocytosis. Further assays indicated that FURIN knockdown enhanced the integrity and reduced the permeability of a monolayer of cultured VECs, which was counteracted by overexpression of THBS1. In a mouse model of atherosclerosis treatment with a FURIN inhibitor decreased VEC apoptosis in atherosclerotic lesions. Overall these results indicate that by cleaving THBS1 and suppressing THBS1 expression FURIN promotes VEC apoptosis and efferocytosis, leading to increased endothelial permeability. These findings provide a new insight into endothelial dysfunction, with atherogenic relevance and potential therapeutic implications. KEY POINTS: Endothelial dysfunction and cell death may lead to endothelial leakage, triggering atherosclerosis. The proprotein convertase FURIN regulates endothelial cell behaviour and promotes atherosclerosis, but its specific mechanisms remain unclear. This study identifies thrombospondin-1 (THBS1) as a novel substrate of FURIN in vascular endothelial cells. FURIN binds to and cleaves THBS1, thereby promoting endothelial apoptosis and efferocytosis, increasing endothelial permeability and impairing vascular homeostasis. These findings provide new insights into endothelial dysfunction with atherogenic and therapeutic relevance.

Indexed as

ApoptosisEndothelial CellsFurinThrombospondin 1AnimalsAtherosclerosisCells, CulturedEfferocytosisHumansMacrophagesMaleMiceMice, Inbred C57BLFurinThrombospondin 1thrombospondin-1, humanapoptosisatherosclerosisefferocytosisendothelial dysfunctionFURINthrombospondin‐1

Identifiers

PMID42227713
PMCPMC13370715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.